What's in Delcath Systems Inc.'s pipeline?

Delcath Systems Inc. has 3 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Delcath Systems Inc.'s portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Associazione Italiana per lo Studio del Pancreas, BeiGene, Beijing Biostar Pharmaceuticals Co., Ltd., Ludwig-Maximilians - University of Munich.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/delcath-systems-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Delcath Systems Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delcath Systems Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
regional chemotherapy	regional chemotherapy	phase 3	Chemotherapy		Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Associazione Italiana per lo Studio del Pancreas · 1 shared drug class
BeiGene · 1 shared drug class
Beijing Biostar Pharmaceuticals Co., Ltd. · 1 shared drug class
Ludwig-Maximilians - University of Munich · 1 shared drug class
Prof. Dr. med. Claus Rödel · 1 shared drug class
Prothena Biosciences Ltd. · 1 shared drug class
Seoul National University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Delcath Systems Inc.:

Cite this brief

Drug Landscape (2026). Delcath Systems Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/delcath-systems-inc. Accessed 2026-06-10.